Shanghai RAAS Blood Products Co Ltd Class A
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. The… Read more
Shanghai RAAS Blood Products Co Ltd Class A (002252) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.001x
Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.25 Million) by net assets (CN¥32.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai RAAS Blood Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
0IHQ
LSE:0IHQ
|
N/A |
|
Guangzhou Haige Communications Group Incorporated Co
SHE:002465
|
-0.018x |
|
Petrobras Distribuidora S.A
PINK:PETRY
|
0.045x |
|
Havells India Limited
NSE:HAVELLS
|
-0.044x |
|
Zhongfu Shenying Carbon Fiber Co. Ltd. A
SHG:688295
|
N/A |
|
MRF Limited
NSE:MRF
|
0.096x |
|
Lynas Rare Earths Ltd
PINK:LYSCF
|
0.026x |
|
Omv Petrom S.A
RO:SNP
|
0.052x |
Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥31.94 Billion | CN¥-482.06 Million | -0.015x | -119.64% |
| 2023-12-31 | CN¥29.65 Billion | CN¥2.28 Billion | 0.077x | +28.28% |
| 2022-12-31 | CN¥28.81 Billion | CN¥1.73 Billion | 0.060x | +19.89% |
| 2021-12-31 | CN¥25.90 Billion | CN¥1.29 Billion | 0.050x | +7.40% |
| 2020-12-31 | CN¥25.13 Billion | CN¥1.17 Billion | 0.047x | -38.76% |
| 2019-12-31 | CN¥11.49 Billion | CN¥872.69 Million | 0.076x | +215.13% |
| 2018-12-31 | CN¥10.89 Billion | CN¥262.50 Million | 0.024x | +13.52% |
| 2017-12-31 | CN¥12.48 Billion | CN¥264.95 Million | 0.021x | -60.98% |
| 2016-12-31 | CN¥11.73 Billion | CN¥638.22 Million | 0.054x | -23.55% |
| 2015-12-31 | CN¥10.71 Billion | CN¥762.42 Million | 0.071x | +31.73% |
| 2014-12-31 | CN¥8.62 Billion | CN¥465.96 Million | 0.054x | +166.06% |
| 2013-12-31 | CN¥1.10 Billion | CN¥-90.11 Million | -0.082x | -131.65% |
| 2012-12-31 | CN¥1.02 Billion | CN¥263.46 Million | 0.258x | +34.61% |
| 2011-12-31 | CN¥927.27 Million | CN¥178.03 Million | 0.192x | -20.29% |
| 2010-12-31 | CN¥831.21 Million | CN¥200.21 Million | 0.241x | +58.49% |
| 2009-12-31 | CN¥763.33 Million | CN¥116.01 Million | 0.152x | +6.57% |
| 2008-12-31 | CN¥754.76 Million | CN¥107.64 Million | 0.143x | -86.20% |
| 2007-12-31 | CN¥170.01 Million | CN¥175.71 Million | 1.034x | +202.38% |
| 2006-12-31 | CN¥156.77 Million | CN¥53.58 Million | 0.342x | +46.61% |
| 2005-12-31 | CN¥231.70 Million | CN¥54.02 Million | 0.233x | -- |